12:00 AM
 | 
Jul 02, 2012
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 6/29 cls
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) BMO Capital Markets Jim Birchenough Price target Market perform 1% $9.98
Jefferies Thomas Wei Price target Buy
Piper Jaffray Edward Tenthoff Price target Overweight
Birchenough raised his target to $12 from $10 after FDA approved Belviq lorcaserin for chronic weight management with "better-than-expected labeling." The Belviq label does not include a REMS or routine monitoring requirement for potential heart value effects, which will instead be assessed in a long-term CV outcomes study (see B10)....

Read the full 732 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >